XML 28 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements
12 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements

5. Fair Value Measurements

The following tables set forth by level within the fair value hierarchy our financial assets and liabilities that were accounted for at fair value on a recurring basis at March 31, 2023 and March 31, 2022:

 

 

 

Balance At

 

 

Quoted Prices
in Active
Markets for
Identical Assets

 

 

Significant Other
Observable Inputs

 

 

Unobservable
Inputs

 

 

 

March 31, 2023

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

Cash and money market funds

 

$

73,754

 

 

$

73,754

 

 

$

 

 

$

 

Commercial paper

 

 

10,795

 

 

 

 

 

 

10,795

 

 

 

 

United States treasury securities

 

 

9,979

 

 

 

 

 

 

9,979

 

 

 

 

Corporate notes and bonds

 

 

3,349

 

 

 

 

 

 

3,349

 

 

 

 

Agency securities

 

 

842

 

 

 

 

 

 

842

 

 

 

 

Total cash and cash equivalents

 

 

98,719

 

 

 

73,754

 

 

 

24,965

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restricted cash and cash equivalents

 

 

7,269

 

 

 

7,269

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

United States treasury securities

 

 

56,890

 

 

 

 

 

 

56,890

 

 

 

 

Agency securities

 

 

37,991

 

 

 

 

 

 

37,991

 

 

 

 

Corporate notes and bonds

 

 

26,590

 

 

 

 

 

 

26,590

 

 

 

 

Commercial paper

 

 

18,141

 

 

 

 

 

 

18,141

 

 

 

 

Total marketable securities

 

 

139,612

 

 

 

 

 

 

139,612

 

 

 

 

TOTAL ASSETS

 

$

245,600

 

 

$

81,023

 

 

$

164,577

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration related to acquisitions

 

$

3,800

 

 

$

 

 

$

 

 

$

3,800

 

Convertible senior notes, net, noncurrent

 

 

266,843

 

 

 

 

 

 

266,843

 

 

 

 

TOTAL LIABILITIES

 

$

270,643

 

 

$

 

 

$

266,843

 

 

$

3,800

 

 

 

 

Balance At

 

 

Quoted Prices
in Active
Markets for
Identical Assets

 

 

Significant Other
Observable Inputs

 

 

Unobservable
Inputs

 

 

 

March 31, 2022

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents (1)

 

$

59,829

 

 

$

59,829

 

 

$

 

 

$

 

Restricted cash and cash equivalents

 

 

6,918

 

 

 

6,918

 

 

 

 

 

 

 

TOTAL ASSETS

 

$

66,747

 

 

$

66,747

 

 

$

 

 

$

 

 

(1)
Cash equivalents consist primarily of money market funds.

We classify our highly liquid money market funds within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. We classify our United States treasury securities, corporate notes and bonds, agency securities, and commercial paper within Level 2 of the fair value hierarchy because they are valued using inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security that may not be actively traded.

During the year ended March 31, 2022, we recorded a fair value adjustment of $7 for the contingent consideration liability related to the acquisition of Topaz based on actual earnout achievement. The contingent consideration liability of $540 was fully settled as of March 31, 2022. The following table presents activity in our financial assets and liabilities measured at fair value using significant observable inputs (Level 2), as of and for the year ended March 31, 2022.

 

 

 

Total Liabilities

 

Balance at March 31, 2021

 

$

533

 

Fair value adjustments

 

 

7

 

Payment of Topaz contingent consideration

 

 

(540

)

Balance at March 31, 2022

 

$

 

As of March 31, 2023, the contingent consideration liability balance of $3,800 relates to the acquisition of TSI Healthcare, LLC (See Note 8) and reflects a $100 post-acquisition fair value adjustment. The following table presents activity in our financial

assets and liabilities measured at fair value using significant unobservable inputs (Level 3), as of and for the year ended March 31, 2023:

 

 

 

Total Liabilities

 

Balance at March 31, 2022

 

$

 

Acquisition

 

 

3,700

 

Fair value adjustments

 

 

100

 

Balance at March 31, 2023

 

$

3,800

 

 

The categorization of the framework used to measure fair value of the contingent consideration liability is within the Level 3 valuation hierarchy due to the subjective nature of the unobservable inputs used. We assess the fair value of the contingent consideration liability on a recurring basis and any adjustments to fair value subsequent to the measurement period are reflected in the consolidated statements of net income and comprehensive income. Key assumptions included probability-adjusted achievement estimates of applicable revenue targets that were not observable in the market. The fair value adjustments to contingent consideration liabilities are included as a component of selling, general and administrative expense in the consolidated statements of net income and comprehensive income. There are no other assets or liabilities accounted for utilizing unobservable inputs (Level 3).

We believe that the fair value of our other financial assets and liabilities, including accounts receivable, accounts payable, and line of credit, approximate their respective carrying values due to their nominal credit risk.

Non-Recurring Fair Value Measurements

We have certain assets, including goodwill and other intangible assets, which are measured at fair value on a non-recurring basis and are adjusted to fair value only if an impairment charge is recognized. The categorization of the framework used to measure fair value of the assets is considered to be within the Level 3 valuation hierarchy due to the subjective nature of the unobservable inputs used.